Xudong Feng
Overview
Explore the profile of Xudong Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Z, Yang Y, Ge C, Tian R, Cheng S, Gao J, et al.
BMC Cancer
. 2025 Jan;
25(1):145.
PMID: 39863897
Introduction: The core objective of this study was to precisely locate metastatic lymph nodes, identify potential areas in nasopharyngeal carcinoma patients that may not require radiotherapy, and propose a hypothesis...
2.
Tao Z, Zhang Y, Kong E, Wei H, Li M, Sun S, et al.
Front Med (Lausanne)
. 2025 Jan;
11:1477099.
PMID: 39760033
Objective: Limb ischemia-reperfusion injury caused by repeated tourniquet application usually leads to acute kidney injury, adversely affecting patient prognosis. This study aimed to investigate the renoprotective effect of remote ischemic...
3.
Zhang S, Sun J, Zhou Q, Feng X, Yang J, Zhao K, et al.
Sci Total Environ
. 2024 Oct;
955:176918.
PMID: 39447912
China's soil is experiencing significant microplastic contamination. We developed a machine-learning model to assess microplastic pollution from 1980 to 2050. Our results showed that the average abundance of microplastics in...
4.
Jian X, Sun Q, Xu W, Qu H, Feng X, Li C
Angew Chem Int Ed Engl
. 2024 Aug;
63(48):e202409867.
PMID: 39172135
Triterpenoids have wide applications in the pharmaceutical and agricultural industries. The glycosylation of triterpenoids catalyzed by UDP-glycosyltransferases (UGTs) is a crucial method for producing valuable derivatives with enhanced functions. However,...
5.
Yao Q, Wang B, Yu J, Pan Q, Yu Y, Feng X, et al.
J Control Release
. 2024 Aug;
374:112-126.
PMID: 39117112
Primary sclerosing cholangitis (PSC) is a challenging cholestatic liver disease marked by progressive bile duct inflammation and fibrosis that has no FDA-approved therapy. Although obeticholic acid (OCA) has been sanctioned...
6.
Gao Y, Feng X, Yuan T, Li M, Wei M, Li S
Diagn Microbiol Infect Dis
. 2024 Apr;
109(3):116293.
PMID: 38598951
Data on people suspected with acute respiratory infections (ARIs) from August 2022 to December 2023 in southern China were analyzed. Following the COVID-19 pandemic, the positive detection rates of respiratory...
7.
Ganesh S, Kim M, Lee J, Feng X, Ule K, Mahan A, et al.
Mol Ther
. 2024 Mar;
32(6):1895-1916.
PMID: 38549376
Malignant tumors are often associated with an immunosuppressive tumor microenvironment (TME), rendering most of them resistant to standard-of-care immune checkpoint inhibitors (CPIs). Signal transducer and activator of transcription 3 (STAT3),...
8.
Feng X, Feng B, Zhou J, Yang J, Pan Q, Yu J, et al.
Hepatology
. 2024 Mar;
PMID: 38546278
Background And Aims: The immunomodulatory characteristics of mesenchymal stem cells (MSCs) make them a promising therapeutic approach for liver fibrosis (LF). Here, we postulated that MSCs could potentially suppress the...
9.
Gao F, Yao Q, Zhu J, Chen W, Feng X, Feng B, et al.
Pharmacol Res
. 2024 Mar;
202:107135.
PMID: 38461139
No abstract available.
10.
Deng Y, Ding H, Zhang Y, Feng X, Ye Q, Tian R, et al.
Heliyon
. 2024 Mar;
10(5):e26853.
PMID: 38439876
Background: Cisplatin (DDP) is the principal agent used for chemotherapy in patients with non-small cell lung cancer (NSCLC). Nevertheless, DDP resistance is an essential cause for a worse prognosis of...